AN IMPROVED PROCESS FOR PREPARING LH-RH AGONIST
The present invention provides an improved process for the preparation of LH-RH agonist by using a novel solid support linker of Formula II.
AN IMPROVED PROCESS FOR PREPARING LH-RH AGONISTS
The present invention provides an improved process for the preparation of LH-RH agonists by using a novel solid support linker of Formula I.
where R\ and R2 are CH3, C2H5, C3H7 and (CH2)n COOH with a proviso that any one of the Rj or R2 is (CH2)n COOH; wherein n is ...
A process for the preparation of Degarelix or a pharmaceutically acceptable salt thereof using combined solid phase peptide synthesis (SPPS) and liquid phase peptide synthesis (LPPS) by Fmoc strategy, proceeding via 9+] fragment protocol and also a process for the preparation of Degarelix or a pharmaceutically accep...
A process for the preparation of Degarelix or a pharmaceutically acceptable salt thereof; using liquid phase peptide synthesis (LPPS) by azide method proceeds via the coupling of suitable N-terminal peptide hydrazide with suitable C-terminal peptide.
ABSTARCT
A PROCESS FOR THE PREPARATION OF PASIREOTIDE
The present invention relates to a process for the preparation of Pasireotide of
formula (I) and its acid addition salts. More particularly the present invention is
directed to a process for the synthesis of Pasireotide of formula (I) having purity greater
t...
The present invention relates to a process for the preparation of Bivalirudin which comprises: providing a protected dipeptide of formula (II), coupling of the protected dipeptide two times to a protected dodecapeptide on a solid support to produce a protected hexadecapeptide fragment of formula (IV); coupling of a ...
The present invention relates to a process for the preparation of Plecanatide. which comprises preparation of three fragments such as Fragment A (7 amino acids). Fragment B (3 amino acids): Fragment C (6 amino acids) and coupling the fragments to provide Plecanatide followed by purification using buffer system com...
The present invention relates to a process for the preparation of Tirzepatide, which comprises preparation of three fragments such as Fragment A (1-12 amino acids), Fragment B (13-39 amino acids), Fragment C (29-39 amino acids); and coupling the fragments B with C to provide fragment D which is on further coupling w...
Documents
Form MGT-14-29122020-signed
Form SH-7-15122020-signed
Optional Attachment-(2)-14122020
Copy of the resolution for alteration of capital;-14122020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-14122020
Altered memorandum of assciation;-14122020
Altered memorandum of association-14122020
Optional Attachment-(1)-14122020
Form PAS-6-07112020_signed
Form MSME FORM I-29102020_signed
Form PAS-3-17102020_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-16102020
Copy of Board or Shareholders? resolution-16102020
Form MGT-7-14102020_signed
List of share holders, debenture holders;-13102020
Copy of MGT-8-13102020
Form AOC-4(XBRL)-22092020_signed
Form PAS-6-11092020_signed
Form MGT-14-01092020_signed
Form DIR-12-01092020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-31082020
Optional Attachment-(1)-31082020
Form MR-1-15062020_signed
Copy of shareholders resolution-15062020
Copy of letter of consent to act as Managing Director/ Whole time Director/Manager ; -15062020
Form PAS-3-01062020_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-01062020
Copy of Board or Shareholders? resolution-01062020